CloudTag Inc. - Final Results
('
Final Results for the year ended
CHAIRMAN'S STATEMENT
The past year has been one of significant progress. The team at
At the same time that we have been creating this operational base, the management team has developed extensive corporate governance policies, processes and procedures to ensure that the Company is able to meet and exceed its corporate responsibility obligations.
On
On behalf of the Board, I would like to thank all of
Chairman
STRATEGIC REPORT
Chief Executive's Review
The 12 months since our last annual report has been one of rapid progress and development for the Company but has also presented its own challenges. I am very proud of what the growing team has achieved both in terms of product development and progress to mass manufacture as well as the commercial and operational aspects of the business.
Strategic overview
Product development
I am pleased to report that the product development effort throughout 2016 resulted in the launch of Onitor, our new brand identity. This work built upon the technical achievements on the underlying technology during 2015 where third party testing underpinned technical accuracy. The Board is aware that there has been investor frustration that the Company did not release its product to the retail market during the year. The Company is determined to ensure that the product's performance marks a step change to other available devices. Detailed R&D has focussed effort on embedded systems electronics and underlying algorithms and we have also undertaken technical work on production and manufacturing processes. We have developed many proprietary algorithms including but not limited to heart rate, ECG energy expenditure and activity recognition. The Company has filed several more patent applications and design registrations and design patents to protect the intellectual property developed by the group.
In tandem with the detailed work to develop the technical capabilities of the product, we have explored opportunities to identify potential markets for our products to seek out niche areas where our technology will stand out from the established operators in the general wearable technology markets. This work has identified a number of B2C openings in the wellness market and prospects in the automotive and e-textile industries.
During the year we undertook an exercise to review our commercial infrastructure which led to the incorporation of a new
Our early stage development work utilised the services of specialist small volume fabrication works for the production of samples for testing and review but it was necessary to review the manufacturing supply chain to ensure that
In order to ensure that we can deliver our products to market we have also established a distribution network designed to cover the initial core markets in the
During the financial year,
As is common with pre-revenue companies, the Board has raised funding on a piecemeal basis as its development work has progressed. Whilst this process provides flexibility and allows the Company to raise funds at prices reflecting the progress made, it does not provide forward visibility of the availability of funds and only limited support for the Board's statement on going concern. The Board recognises that many short term investors will not be happy that the trading platform historically provided through our listing on AIM has come to an end and this avenue of funding will no longer be available to the Company. Nevertheless, the majority of our fundraising has come from long term private investors and the Board is confident that the Company will continue to receive the support of these individuals such that it can continue to raise the funds required to support the Company to enable it to continue to operate on a day-to-day basis.
The Board of
Review of the period
A summary of highlights during the period include:
During the period from
· Exhibited first product set, the Cloudtag Track™ and the beatSMART™ Clip on schedule, at the Consumer Electronics show,
· Signed a distribution agreement with
· Appointed Dr
· Signed exclusive strategic commercial license agreement with
· Successful testing with the Human Performance Unit at the
· Reduction in Company's indebtedness through the conversions of loans at preferential rates for the Company and conversion of certain creditors;
· Investment in areas of strategic focus whilst reducing costs in non-core areas. Maintained R&D spend while increasing expenditure on items with lasting benefits including for manufacturing and one-off tooling costs, sales, marketing and business development;
· Successful fundraisings of
· Formation of two new
· Appointment of Chief Creative Officer, Mr
· Signed a binding heads of terms with
· Completed a switch to a high-volume manufacturer in
· Appointment of Director of Sales, Mr Bhav Dattani, with many years of relevant industry experience having previously been the Head of Sales for
· Appointment of in-house chief legal counsel,
· Appointment of Chief Business Development Officer, Mr
During the financial year, the Company recorded a loss before taxation of
We were pleased to see this progress continue into the period post the year end, highlights during this period included:
· Fundraising totalling
· Appointment of
· Final form agreement signed with
· Entered into a distribution agreement with
· Launch of the new Company brand Onitor under which the Company's product, the Onitor Track is being launched, including a new consumer focussed website; and
· Exhibited at the Consumer Electronics Show 2017 in
Summary
While the first quarter of 2017 has had its challenges, we would like to thank all of our dedicated shareholders for their continued support during this unsettling period.
Looking forwards, we have built a strong and vastly experienced team across all areas of the business, positioning us well to take advantage of the commercial opportunities for the Onitor Track release to both B2C and B2B consumers as well as developing the product road map for 2017 and beyond. I look forward to bringing updates to our shareholders as and when we make progress in line with this strategy.
Business risks
There are a number of potential risks and uncertainties which could adversely impact the achievement of our corporate aims.
The Group faces risks frequently encountered by new companies. In particular, its future growth and prospects will depend on its ability to fund and manage growth and to continue to expand and improve operational, financial and management information and quality control systems on a timely basis, whilst at the same time maintaining effective cost controls.
In order to mitigate these risks the Company maintains regular dialogue with its existing investors and the wider financial community regarding the possibility of providing additional funding as and when required. The Company's Chief Executive and executive management applies dynamic management tools to reduce both technological and financial risks on a daily basis and maintains systems commensurate with the current stage of the business. Strategies have been put in place for further appropriate systems and management tools for when revenue streams commence later in 2017.
Progress to Mass Manufacture & Commercial Launch
Reliance on third-party contractors
The Company has brought much of the core technical know-how, research, development and commercialisation of the product in-house and appointed an experienced technical and operational management team to mitigate risks related to the reliance of third party contractors. Key strategic third party suppliers continue as equity partners in the Company, therefore aligning all parties interests in delivering a successful product.
However, the Group does rely on certain third party contractors to manufacture, assemble and test its products and its failure to successfully manage relationships with these contractors could in turn damage
issues arise.
Legal and contractual risks
To mitigate this risk, the Company has appointed its own in house legal counsel and has appointed experienced executives with acute business acumen to negotiate contracts. These individuals also engage lawyers with suitable expertise in the respective fields of commercial law to ensure contractual terms are valid, and secondly wherever possible contracts are written subject to English law and enforced by English courts.
Impact of negative press
The Company cannot guarantee that those parties that currently or will endorse its products have not conducted themselves in the past and will not conduct themselves in the future in such a way as to bring negative publicity upon the Company. There is the risk that the above situation, or any product failure, may be of a high profile nature. The Company is careful to conduct due diligence and to vet its contractors to ensure a high standard of conduct in order to mitigate this risk. Negative press may also impact on the Company's ability to raise additional funding.
Product liability
The Group may become exposed to product liability risks arising from the use of its technology in consumer products which, if not adequately covered by insurance, may have a material adverse effect upon the Group's financial condition.
The Company seeks to ensure that its insurance cover is adequate for perceived material risks. Furthermore, all of the Company's literature contains disclaimers and protections.
Competition/competing technology
The markets in which the Group expects to operate are competitive and fast moving and may become even more competitive. There can be no guarantee that the Group's competitors will not develop similar or superior technology or offer superior product applications or services to the Group's target markets which may render one or more of
This risk is mitigated by the large barriers to entry to competitors looking to develop similar technology. This includes, but is not limited to, the large intellectual property estate, namely the 11 years of research and development to which the Company has an exclusive world wide perpetual license and the filing of a number of patents covering the unique, in-house- designed sensors and signal processing algorithms for both the hardware and software of the sensors, the innovative sensors design and the mechanical body attachment. Further protection is afforded by the highly skilled technical development team led by a globally experienced and proven management team to develop these cutting edge and innovative technologies.
Across the Group,
Economic climate
The trading activities of the Group will, to a certain extent, be dependent on the economic environment. This risk is mitigated by the size and growth indicators of the wearable technology market. At present the market is one of the fastest growing technology markets in history and is predicted to reach
Financial risk management objectives and policies
The Group's principal financial instruments comprise cash and cash equivalents. The Group has various other financial instruments such as trade receivables and trade payables, which arise directly from its operations.
The Group is exposed to a variety of financial risks which result from both its operating and investing activities. The Directors are responsible for co-ordinating the Group's risk management and focus on actively securing the Group's short to medium term cash flows. The Group does not actively engage in the trading of financial assets and has no financial derivatives. The most significant risks to which the Group is exposed are described below:
Cash flow risks
The Group seeks to manage risks to ensure sufficient liquidity is available to meet foreseeable needs by investing cash assets safely and profitably. The Directors prepare rolling cash flow forecasts and seek to identify the need and raise additional funding whenever a shortfall in facilities is forecast. The delisting of the Company's shares from trading on AIM removes one avenue of funding but, as evidenced during the financial year and post year, end the Company's Chief Executive has been able to raise additional funds as and when required. Further information on going concern is given below.
Currency risks
The Group does not seek to hedge its foreign exchange risk and the Directors consider that the exposure to movements in foreign currencies is not significant. The impact of Brexit on the Company is uncertain but will be monitored as the process advances. At the time when the Directors consider that exposure to foreign exchange trading risks becomes significant they will seek to adopt appropriate hedging strategies and products.
Going concern
At
The Directors have considered the cash requirements of the business for the next 12 months. As part of this process, they have prepared detailed cash flow projections which assume that no revenue is generated by the Group. These projections assume that all avoidable costs can be reduced. The forecasts show that the Company will need to raise further funds from external sources to enable it to continue trading and continue with product development.
The Company's AIM nominated adviser has resigned and a new Nominated Adviser has not been appointed. As a consequence, trading of the Company's securities on AIM will be cancelled on
Although the projections used for this purpose assume no revenue is generated, the Directors believe that the Group will launch its first product during the forthcoming twelve months with associated revenue generation. Although revenue generation and the amount of such revenue is uncertain, any such revenues generated would reduce the amount of new finance necessary to support the Business. The directors are continuing to explore alternative sources of finance and have prepared the financial statements on the going concern basis on the assumption that such sources of finance will be found to enable the development of the product to continue.
Chief Executive Officer
CONSOLIDATED STATEMENT OF COMPREHENSIVE INCOME
For the year ended
|
|
Note |
Year ended |
|
Year ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
Operational, development, manufacturing and administrative expenses |
|
|
|
|
|
Options and warrants issued in payment of remuneration and services |
|
(1,532) |
|
(430) |
|
Research and development costs |
|
(2,846) |
|
(698) |
|
Other administrative expenses |
|
(3,843) |
|
(846) |
|
|
|
|
|
|
|
Total operational and administrative expenses |
|
(8,221) |
|
(1,974) |
|
Loss from operations |
|
(8,221) |
|
(1,974) |
|
|
|
|
|
|
|
Finance cost |
|
(98) |
|
(15) |
|
Loss before taxation |
|
(8,319) |
|
(1,989) |
|
|
|
|
|
|
|
Taxation |
|
12 |
|
125 |
|
|
|
|
|
|
|
Loss after taxation and loss attributable to the equity holders of the Company and total comprehensive income for the period |
|
(8,307) |
|
(1,864) |
|
|
|
|
|
|
|
Loss per share |
|
|
|
|
|
Total basic and diluted (pence per share) |
|
(3.07) |
|
(1.06) |
All of the activities of the Group are classed as continuing.
CONSOLIDATED STATEMENT OF CHANGES IN EQUITY
For the year ended
|
|
|
Share capital |
|
Share premium |
|
Convertible loan notes |
|
Retained earnings |
|
Total equity |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Balance at |
|
154 |
|
3,719 |
|
- |
|
(4,487) |
|
(614) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of convertible loan notes |
|
- |
|
- |
|
1,050 |
|
- |
|
1,050 |
|
Conversion of convertible loan notes |
|
34 |
|
816 |
|
(850) |
|
- |
|
- |
|
Issue of share capital |
|
17 |
|
554 |
|
- |
|
- |
|
571 |
|
Share issue costs |
|
- |
|
(268) |
|
- |
|
- |
|
(268) |
|
Transactions with owners |
|
51 |
|
1,102 |
|
200 |
|
- |
|
1,353 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and warrants issued in payment of remuneration and services |
|
- |
|
- |
|
- |
|
430 |
|
430 |
|
Suppliers paid in warrants |
|
- |
|
- |
|
- |
|
34 |
|
34 |
|
Loss for the period |
|
- |
|
- |
|
- |
|
(1,864) |
|
(1,864) |
|
Balance at |
|
205 |
|
4,821 |
|
200 |
|
(5,887) |
|
(661) |
|
|
|
|
|
|
|
|
|
|
|
|
|
Issue of convertible loan notes |
|
- |
|
- |
|
50 |
|
- |
|
50 |
|
Conversion of convertible loan notes |
|
12 |
|
188 |
|
(200) |
|
- |
|
- |
|
Issue of share capital |
|
149 |
|
5,915 |
|
- |
|
- |
|
6,064 |
|
Share issue costs |
|
- |
|
(6) |
|
- |
|
- |
|
(6) |
|
Transactions with owners |
|
161 |
|
6,097 |
|
(150) |
|
- |
|
6,108 |
|
|
|
|
|
|
|
|
|
|
|
|
|
Options and warrants issued in payment of remuneration and services |
|
- |
|
- |
|
- |
|
1,532 |
|
1,532 |
|
Loss for the period |
|
- |
|
- |
|
- |
|
(8,307) |
|
(8,307) |
|
Balance at |
|
366 |
|
10,918 |
|
50 |
|
(12,662) |
|
(1,328) |
CONSOLIDATED STATEMENT OF FINANCIAL POSITION
At
|
|
|
|
|
|
|
|
|
|
|
|
|
Assets |
|
|
|
|
|
|
|
|
|
|
|
Fixed assets |
|
|
|
|
|
Property, plant and equipment |
|
24 |
|
1 |
|
|
|
|
|
|
|
Current |
|
|
|
|
|
Trade and other receivables |
|
426 |
|
143 |
|
Cash and cash equivalents |
|
30 |
|
16 |
|
|
|
|
|
|
|
Total current assets |
|
456 |
|
159 |
|
|
|
|
|
|
|
Total assets |
|
480 |
|
160 |
|
|
|
|
|
|
|
Liabilities |
|
|
|
|
|
Current |
|
|
|
|
|
Trade and other payables |
|
1,415 |
|
521 |
|
Loans |
|
163 |
|
300 |
|
|
|
|
|
|
|
Total current liabilities |
|
1,578 |
|
821 |
|
|
|
|
|
|
|
Liabilities due after one year |
|
|
|
|
|
Loans |
|
230 |
|
- |
|
|
|
|
|
|
|
Total liabilities |
|
1,808 |
|
821 |
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
Issued share capital |
|
366 |
|
205 |
|
Share premium |
|
10,918 |
|
4,821 |
|
Convertible loans |
|
50 |
|
200 |
|
Retained earnings |
|
(12,662) |
|
(5,887) |
|
Equity attributable |
|
|
|
|
|
to owners of the company |
|
(1,328) |
|
(661) |
|
|
|
|
|
|
|
Total equity and total liabilities |
|
480 |
|
160 |
The consolidated financial statements were approved by the Board on
A Ben-Haim
Director
CONSOLIDATED CASH FLOW STATEMENT
For the year ended
|
|
|
Year ended |
|
Year ended |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Operating activities |
|
|
|
|
|
Loss after tax |
|
(8,307) |
|
(1,864) |
|
Share based payments |
|
1,532 |
|
430 |
|
Depreciation |
|
5 |
|
1 |
|
Finance cost |
|
98 |
|
15 |
|
Income tax credit to profit or loss |
|
(12) |
|
(125) |
|
Fees paid in shares |
|
1,407 |
|
207 |
|
Increase in trade and other receivables |
|
(133) |
|
(9) |
|
Increase/(decrease) in trade and other payables |
|
891 |
|
(187) |
|
Net cash outflow from operating activities |
|
(4,519) |
|
(1,532) |
|
|
|
|
|
|
|
Income tax receipts |
|
137 |
|
255 |
|
Net cash outflow from operating activities after taxation |
|
(4,382) |
|
(1,277) |
|
|
|
|
|
|
|
Cash flows from investing activities |
|
|
|
|
|
Purchase of property, plant and equipment |
|
(28) |
|
- |
|
Net cash outflow from financing activities |
|
(28) |
|
- |
|
|
|
|
|
|
|
Financing activities |
|
|
|
|
|
Proceeds from issue of share capital |
|
4,432 |
|
983 |
|
Share issue costs |
|
(6) |
|
- |
|
Other loans advanced |
|
204 |
|
300 |
|
Other loans repaid |
|
(179) |
|
- |
|
Finance cost |
|
(27) |
|
(15) |
|
Net cash inflow from financing activities |
|
4,424 |
|
1,268 |
|
|
|
|
|
|
|
Net change in cash and cash equivalents |
|
14 |
|
(9) |
|
Cash and cash equivalents at beginning of period |
|
16 |
|
25 |
|
Cash and cash equivalents at end of period |
|
30 |
|
16 |
NOTES
1. Basis of Preparation
The Company was incorporated in the
The Group's shares are, until
The principal accounting policies applied by the Group are set out in the Company's financial statements. These policies have been consistently applied to all the periods presented, unless otherwise stated.
The financial information set out in this preliminary announcement does not constitute statutory accounts. The consolidated statement of financial position at
2. Segmental Information
An operating segment is a distinguishable component of the Group that engages in business activities from which it may earn revenues and incur expenses, whose operating results are regularly reviewed by the Group's chief operating decision maker to make decisions about the allocation of resources and an assessment of performance and about which discrete financial information is available.
The chief operating decision maker has defined that the Group's only operating segment during the period is the development of physiological technology. All of the corporate headquarter costs are allocated to this segment.
The Group has not generated any revenues from external customers during the period.
In respect of the non-current assets all (2015: all) arise in the
3. Loss per share
|
|
Year ended |
|
Year ended |
|
|
|
|
|
|
|
|
|
|
|
Loss on ordinary activities after tax ( |
(8,307) |
|
(1,864) |
|
|
|
|
|
|
Weighted average number of shares for calculating basic loss per share |
270,594,687 |
|
176,281,283 |
|
|
|
|
|
|
Basic and diluted loss per share (pence) |
(3.07) |
|
(1.06) |
There are 29,700,000 share options and 58,683,334 warrants unexercised as detailed in note 8. Their effect is anti-dilutive, but are potentially dilutive against future profits. Additionally, there is an amount of
Since the year end a further 81,677,376 shares have been issued, and there has been a net increase in the warrants in issue of 58,041,478 whose impact is potentially dilutive.
4. Going concern - significant uncertainty
In forming our opinion on the financial statements, we have considered the adequacy of the disclosures made in the principal accounting policies of the financial statements concerning the Group's ability to continue as a going concern.
The Group incurred a net loss of
5. Publication of Annual Report and Notice of AGM
The accounts for the year ended
|
|
+1 345 949 45 44 |
This information is provided by RNS
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE